N Engel
Overview
Explore the profile of N Engel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engel N, Apolosi I, Bhargava A, Bhan A, Celan C, Mak A, et al.
Int J Tuberc Lung Dis
. 2024 Oct;
28(11):517-520.
PMID: 39468025
Reducing systemic inequities in testing, access to care, social protection - and in the scientific process - is essential to end TB. Incorporating social science methods and expertise on inequity...
2.
Basile F, Bijker E, Sekadde M, Dorman S, Ellner J, Engel N, et al.
IJTLD Open
. 2024 Sep;
1(9):425-427.
PMID: 39301132
No abstract available.
3.
Seidel C, Schaefers C, Connolly E, Weickhardt A, Grimison P, Wong V, et al.
ESMO Open
. 2024 May;
9(5):103449.
PMID: 38744098
Background: In relapsed or refractory (RR) metastatic germ cell cancer (GCC), high-dose (HD) chemotherapy (CTX) plus autologous stem cell transplantation is considered the standard of care. Limited data exist regarding...
4.
van de Berg S, Pelzer P, van der Land A, Abdrakhmanova E, Ozi A, Arias M, et al.
BMC Public Health
. 2021 Jul;
21(1):1404.
PMID: 34271884
Background: BPaL, a 6 month oral regimen composed of bedaquiline, pretomanid, and linezolid for treating extensively drug-resistant tuberculosis (XDR-TB) is a potential alternative for at least 20 months of individualized...
5.
Daftary A, Furin J, Zelnick J, Venkatesan N, Steingart K, Smelyanskaya M, et al.
Int J Tuberc Lung Dis
. 2020 Dec;
24(12):1312-1315.
PMID: 33317679
No abstract available.
6.
Macintyre K, Bakker M, Bergson S, Bhavaraju R, Bond V, Chikovore J, et al.
Int J Tuberc Lung Dis
. 2017 Oct;
21(11):87-96.
PMID: 29025490
Crucial to finding and treating the 4 million tuberculosis (TB) patients currently missed by national TB programmes, TB stigma is receiving well-deserved and long-delayed attention at the global level. However,...
7.
Pai N, Smallwood M, Gulati D, Lapczak N, Musten A, Gaydos C, et al.
AIDS Behav
. 2017 Apr;
22(2):606-615.
PMID: 28439755
Human immunodeficiency virus (HIV) self-testing presents an empowering alternative to facility-based testing for reaching undiagnosed HIV infected individuals, but is not currently available in Canada. We surveyed stakeholders (clinical providers,...
8.
Craig G, Daftary A, Engel N, ODriscoll S, Ioannaki A
Int J Infect Dis
. 2016 Nov;
56:90-100.
PMID: 27810521
Tuberculosis (TB)-related stigma is an important social determinant of health. Research generally highlights how stigma can have a considerable impact on individuals and communities, including delays in seeking health care...
9.
Cricco G, Engel N, Croci M, Davio C, Martin G, Fitzsimons C, et al.
Inflamm Res
. 2016 Aug;
46(Suppl 1):59-60.
PMID: 27518003
No abstract available.
10.
Zoellner A, Fritsch S, Prevalsek D, Engel N, Hubmann M, Reibke R, et al.
Bone Marrow Transplant
. 2015 Feb;
50(5):679-84.
PMID: 25642765
Prognosis is poor for patients with biologically aggressive Non-Hodgkin lymphoma (NHL), refractory to chemotherapy or relapsed after autologous transplantation, especially when no disease control before allogeneic transplantation is achieved. In...